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Introduction
Thrombocytopenia is commonly seen in critically ill
intensive care unit (ICU) patients and the incidence varies
between 35 and45%.1 This incidence is slightly higher in
cardiac intensive care unit (CICU), particularly those who
require cardiopulmonary bypass (CPB).2 The presence of
thrombocytopenia not only increases the risk of bleeding
after CPB but also influences the patient management in
CICU.3 Decision about invasive lines placement and
initiation of anticoagulation after surgery may be
delayed. 
Drop in platelet count (PC) in cardiac surgery is mainly
due to haemodilution, platelet activation due to contact
with extra corporeal circuit and heparin-induced
thrombocytopenia (HIT). Significant platelet activation
occurs after on-pump coronary artery bypass grafting
(CABG) when compared with off-pump CABG.2,4
Maximum drop in PC after CPB is usually seen between
day one to day four,5,6 after which the PC usually starts to
recover. In addition, PC may also be reduced due to
sepsis, post-transfusion thrombocytopenia,7 drug-
induced and thrombotic thrombocytopenic purpura
(TTP). Sepsis is usually associated with moderate
reduction in PC while severe thrombocytopenia (<
50,000 x 109/L) is usually due to disseminated
intravascular coagulation (DIC).
Two types of patterns have been described in HIT
patients. The incidence of these two patterns in cardiac
patients is around 21%8 and it can be used as a potential
diagnostic criterion for HIT patients.  In pattern 1, the drop
in PC recovers within 5 days after cardiac surgery and then
again starts to drop and remain low beyond 7 days. The
second pattern is described as persistent drop of PC for 7
- 10 days without recovery.
Large doses of unfractionated heparin (UFH) are used in
cardiac surgeries to prevent extracorporeal circuit-related
thrombosis. Advantages of UFH include short half-life and
easy monitoring during CPB by measuring activated
clotting time (ACT). In addition, it can be easily reversed
by protamine sulphate. The use of UFH is associated with
higher risk than low molecular weight heparin (LMWH) in
post-operative period. CPB induces the release of platelet
factor 4 (PF4) in circulation, which combines with heparin
to form a heparin-PF4 complex.5,6 Antibodies against this
complex can be detected in 50% of post-cardiac surgery
patients,7 but very few proceed to heparin HIT. HIT (type II)
is diagnosed when antibodies are detected along with
clinical manifestations. Thrombosis is usually seen in
venous circulation and may present with adrenal
haemorrhage due to adrenal vein thrombosis and
necrosis. Although the absence of antibodies against
complex rule out HIT, its presence does not confirm the
diagnosis. Interestingly, various studies have shown that
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Abstract
Objective: To observe the incidence and pattern of thrombocytopenia in cardiac surgery patients.
Methods: This prospective, cohort study was conducted at the Aga Khan University Hospital, Karachi, from
November 2014 to April 2015, and comprised adult cardiac patients. Patients with platelet count less than 150,000
x 109/L, history of malignancy, immune thrombocytopenic purpura and on chemo or radiotherapy were excluded.
All information including demographics, platelet count, heparin doses, total cardiopulmonary bypass time, cross-
clamp time, blood products transfused, any thromboembolic complication and the presence of infection were
recorded on a pre-designed proforma. SPSS 19 was used for data analysis.
Results: Of the 177 patients, 130(73.4%) were males and 47(26.6%) were females. The overall mean age was
59.21±10.99 years. Thrombocytopenia was observed in 167(94.4%) patients. Of them, platelet count dropped below
50% in 71(42.5%) patients, 30-50% in 68(40.7%) patients and 20-30% in 28(16.8%) from the baseline value.
Regarding pattern of thrombocytopenia, maximum drop in platelet count was noticed on 2nd and 3rd day of
surgery. Furthermore, 9(5.3%) patients developed severe thrombocytopenia (<50,000 x 109/L). 
Conclusion: The incidence of thrombocytopenia and its severity after cardiac surgery was very high in our study
population when compared with western population. 
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4-20% of cardiac surgery patients already have antibodies
pre-operatively.6
The current study was planned to differentiate the pattern
of thrombocytopenia and its incidence among Pakistani
population coming for cardiac surgeries
(elective/emergencies) on CPB, as compared to the
Western population.
Patients and Methods
This prospective, cohort study was conducted at the
cardiac operating room and CICU of the Aga Khan
University Hospital (AKUH), Karachi, from November 2014
to April 2015, and comprised adult cardiac patients.
Approval for the study was obtained from the institutional
ethics review committee. Written informed consent was
taken from all the patients. Patients aged between 35 and
70 years were included. Non-probability consecutive
sampling technique was used. Patients with platelet
count less than 150,000 x 109/L, history of malignancy,
immune thrombocytopenic purpura (ITP) and those who
were on chemo or radiotherapy were excluded.
Standard anaesthesia protocols were followed in each
patient. Intravenous UFH 400 IU/kg was used in all
patients to achieve ACT > 480 seconds before CPB. This
value was maintained during the CPB period using
additional heparin. The effect of heparin was reversed by
protamine sulphate after coming off CPB. First blood
sample was drawn as soon as patient arrived in the ICU. 
All data was documented on a proforma, which included
demographics, PC at different intervals (days 0 - 9),
heparin doses, total CPB time, cross clamp time and blood
products transfused. Any thromboembolic complication
(myocardial infarction (MI), stroke, arterial or venous
thrombosis) and the presence of infection were also
recorded during the patients' CICU stay. SPSS 19 was used
for data analysis. Incidence of thrombocytopenia was
computed. Frequency and percentage were computed for
categorical variables and analysed by chi-square test.
Kolmogorov-Smirnov test was used to check normality for
numeric data. For normally distributed data, mean and
standard deviation were estimated and analysed by
analysis of variance (ANOVA). Median and interquartile
range (IQR) were computed for non-normal data and
analysed by Kruskal-Wallis test. Paired t-test was also
applied to observe difference in mean platelet count
before and after each follow-up. P<0.05 was considered
significant.
Results
Of the 177 patients, 130(73.4%) were males and 47(26.6%)
were females. The overall mean age was 59.21±10.99
years. Hypertension 131(74%) and diabetes mellitus
89(50.3%) were the most common comorbids among
participants. Type of surgeries included CABG 139(78.5%),
mitral valve replacement (MVR) 12(6.8%), aortic valve
replacement (AVR) 10(5.6%) and miscellaneous surgeries
that required CPB (Table-1).
The mean pre-operative PC of all the patients was
261.96±70.15 x 109/L. Thrombocytopenia was observed in
167(94.4%) patients who developed post-operative drop
in PC below 150,000 x109/L. Of them, PC dropped below
50% in 71(42.5%) patients, to 30-50% in 68(40.7%)
patients and to 20-30% in 28(16.8%) patients from the
baseline during the course of CICU. Maximum drop in PC
was noticed on 2nd and 3rd day of surgery. These patients
were followed for 10 days. Lowest PC was seen in
44(24.9%) patients on the same day of surgery and in
79(44.6%) patients on day 1. Besides, 9(5.38%) patients
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CABG + Valve 4(2.3%)
CABG + CaroitedEndoterectomy 2(1.1%)
BMI: Body mass index
IHD: Ischemic heart disease
CKD: Chronic kidney disease
NSTEMI: Non-STsegment elevation myocardial infarction
CABG: Coronary artery bypass grafting
AVR: Aortic valve replacement
DVR: Double valve replacement
MVR: Mitral valve replacement
TVR: Tricuspid valve replacement.
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Table-2:  Comparison of characteristics among thrombocytopenia patients (n=167).
Variables Platelet Count Decrease from BL P-Values
20% to 30% (n=28) 31% to 50% (n=68) >50% (n=71)
Preoperative exposure to unfractioned (IV) Heparin 2(7.1%) 3(4.4%) 4(5.6%) 0.85†
Preoperative Exposure to LMWH Heparin 5(17.9%) 3(4.4%) 10(14.1%) 0.07†
Total Cross Clamp Time (min) 63.71±29.64 68.16±25.72 81.66±35.64 0.009‡
Total CPB time (min) 100.3±36.00 103.01±31.06 121.93±42.78 0.004‡
Total PRBCs transfusion in the OR 0.11*
n 10 34 46
Median[IQR] unit 1[1] 1.5[1] 2[1]
Total Platelet transfused in the OR 0.41*
n 2 5 12
Median[IQR] 4.5[0] 5[2] 4[2]
How many gelofusine transfused in the OR 507.14±71.64 517.65±105.01 504.23±145.83 0.79 ‡
Clinical diagnosis of coagulopathy in the OR 0 1(1.5%) 0 0.48†
Results are presented as mean±SD, Median [IQR] and n(%). †Chi-square test,   ‡ANOVA,    *Kurskal-Wallis test. 
BL: Baseline. LMWH: Low molecular weight heparin. IV: Intravenous. CPB: Cardiopulmonary bypass. PRBCs: Packed red blood cells. OR: Operating room. IQR: Interquartile range. ANOVA: Analysis of variance.
SD: Standard deviation.
Figure: Pattern of thrombocytopenia in cardiac surgery patients [A]. All patients, n=177 [B]. Pattern
II (persistent thrombocytopenia) seen in 5 patients[C] Uncomplicated course, n= 172.
(Paired t test,  †<0.01 significantly decrease from pre-operative).
developed severe thrombocytopenia (<50,000 x 109/L).
The incidence of thrombocytopenia was high in patients
who required longer cross-clamp time and CPB time
(Table-2). 
Platelet transfusion was required in 19(10.7%) patients in
operating room and 29(16.4%) patients in the CICU. There
was an association between blood transfusion and
severity of thrombocytopenia. 
Discussion
Monitoring of PC after cardiac surgery is important for
various reasons. Firstly, it helps in the diagnosis of a
serious condition called HIT. In addition, the decision
about continuation of heparin (LMWH or UFH) after
surgery has also become an important issue. The
incidence of HIT in cardiac surgery patients is 1-2%.6 It is
also difficult to diagnose as we cannot rely on low platelet
count alone. Although the presence of thrombocytopenia
is essential for diagnosing HIT, its incidence is very high
after cardiac surgery. Diagnosis is based on clinical
findings and various laboratory tests.
Different patterns of platelet changes have been
mentioned after cardiac surgery. These patterns include
pattern I (biphasic drop in PC), pattern II (persistent drop)
and more common scenario (transient drop in PC) in
initial 2-3 days and then gradual increase. Despite the
presence of low PC and antibodies in cardiac patients
after surgery, the incidence of HIT is very low.
HIT is usually seen in pattern 1, where the
thrombocytopenia is biphasic. The initial drop is followed
by transient rise in PC and then the count falls again. In
the present study, we were unable to find pattern 1, may
be due to the inadequate sample size to reveal this
pattern. None of the patients in our study showed any
thrombotic complications and laboratory tests were not
done in any of these patients.
Early onset and persistent thrombocytopenia (pattern II)
was seen in 5(2.99 %) patients in our study (Figure). These
patients showed persistent drop of PC (<100,000 x 109/L)
till 7 days, after which three of these patients started to
recover and by the 9thpost-operative day (POD) their PC
were>100,000. Only two patients had PC<100,000 even
on 9th POD. They also showed severe thrombocytopenia
(<50,000 x 109/L).Selling et al.9 disagree with the previous
studies that type II pattern is also associated with HIT,
even in the presence of positive antibody test. They also
found 4.3% patients with early onset (<4 days) and
persistently (7 days) reduced PC after cardiac surgery.
They also noticed high 30 days' mortality rate (12%) in
these patients. This pattern is most probably due to
causes other than HIT and if anticoagulation is required
then heparin can be continued in these patients.10
Pouplard et al.7 also agree that pattern II is less specific for
HIT but they also suggested that tests should be done to
confirm the presence of HIT if PC remains low after 6 days
post-operatively. PC should start to recover within 7-10
days after heparin stoppage in HIT patients. Four out of
five patients showed some recovery after persistent drop
of PC for 7 days. We are not sure whether HIT causes this
initial drop and improvement or other factors like sepsis.
Around 82.4% patients developed more than 30% drop in
PC after surgery (Figure). More important finding was that
>50% drop in PC was seen in 41.5% of patients, which is
higher than the previous study in the same institution.5
Transient decrease in PC is common after cardiac surgery
due to haemodilution, mechanical disruption,
sequestration in the lungs, platelet consumption in the
wounds and contact of blood with extra corporeal circuit
leading to platelet activation and adhesion. Usually, PC
nadir is seen on 2nd or 3rd day after cardiac surgery, with
subsequent increase in PC (Figure). In our study, the
lowest PC fall was seen on day 1 when 79 patients showed
lowest count. Only one patient showed the lowest count
after five days (on the 7th day).
Association between CPB time and severity of PC
reduction was also noticed in our study (Table-2). Long
CPB time requires more frequent doses of heparin and
longer contact time with extracorporeal circuit, which
may cause not only destruction of platelets but also
platelet activation and release of large amount of PF4.
Drop in platelet count and function is less pronounced in
off-pump CABG. 
We were unable to find any association of individual
anaesthetist, perfusionist or surgeon on the severity of
thrombocytopenia. The amount of heparin given by
anaesthetists and perfusionist also had no effect on drop
in PC.
Moreover, 5.3% of our patients showed severe
thrombocytopenia (PC <50,000), which is higher than
another study conducted in post-cardiac surgery patients
in ICU.9 In that study 2.9% showed severe
thrombocytopenia. They also found 12% mortality in
patients who continued to have persistent
thrombocytopenia even after day 4.
Post-transfusion purpura with severe thrombocytopenia
is more common in females and developed within two
weeks of blood transfusion. When previously exposed
females receive blood/ Platelet transfusion, it triggered a
B cell-mediated immune response with increase in
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antibodies against human platelet antigen, which destroy
normal platelets. 
One of the limitations of the current study was that the
patients were not followed for longer period of time to
see changes in PC and for any thrombotic complication.
Additionally, antibodies for PF4-heparin test were not
done, particularly in suspected patients who showed
pattern II.
Further studies with larger study population and
immunological testing in suspected patients are needed
to fully evaluate the thrombocytopenia in cardiac surgery
patients.
Conclusion
The incidence of thrombocytopenia and its severity after
cardiac surgery was very high in our study population
when compared with western population. We were
unable to find usual HIT pattern in any patient which may
signify that the incidence of HIT was very low in our
population.
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